The Expression of Lipoprotein Receptors Is Increased in the Infarcted Area After Myocardial Infarction Induced in Rats With Cardiac Dysfunction
Carregando...
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
LIPIDS, v.53, n.2, p.177-187, 2018
Resumo
Left ventricular (LV) remodeling after myocardial infarction constitutes the structural basis for ventricular dysfunction and heart failure. The characterization underlying the expression of lipoprotein receptors in cardiac dysfunction is scarcely explored. The aim of this study was to analyze the status of lipoprotein receptors on the infarcted and noninfarcted areas of LV and to verify whether nano particles that mimic the lipid structure of low-density lipoprotein (LDL) and have the ability to bind to LDL receptors (LDE) are taken up more avidly by the noninfarcted LV. 13 male Wistar rats with left coronary artery ligation (myocardial infarction [MI]) and 12 animals with SHAM operation (SHAM) were used in this study. 6 weeks after the procedure, the quantification of low-density lipoprotein receptor (LDLR), LDL receptor-related protein 1 (LRP1), scavenger receptor-class B type I (SR-BI) lipoprotein receptors, and PCNA proliferation marker, and tissue uptake of radioactively labeled LDE were performed. Immunohistochemistry and Western blot analysis showed that LDLR, LRP1, SR-BI, and PCNA, expression in infarcted area of MI was remarkably higher than SHAM and noninfarcted subendocardial (SEN) and interstitial (INT) areas. In addition, in SEN noninfarcted area of MI, the presence of LDLR was about threefold higher than in SHAM SEN and INT noninfarcted areas. The LDE uptake of noninfarcted LV of MI group was about 30% greater than that of SHAM group. In conclusion, these findings regarding the status of lipoprotein receptors after MI induction could help to establish mechanisms on myocardial repairing. In conclusion, infarcted rats with LV dysfunction showed increased expression of lipoprotein receptors mainly in the infarcted area.
Palavras-chave
Coronary artery disease, Heart lipid metabolism, Lipoprotein receptors
Referências
- Abbey M, 1999, MATURITAS, V33, P259, DOI 10.1016/S0378-5122(99)00054-7
- Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701
- Campos H, 1997, J CLIN ENDOCR METAB, V82, P3955, DOI 10.1210/jc.82.12.3955
- Chan DC, 2015, CLIN SCI, V128, P379, DOI 10.1042/CS20140559
- COBELLI C, 1987, AM J PHYSIOL, V253, pE551
- Crook D, 1998, CONTRACEPTION, V57, P189, DOI 10.1016/S0010-7824(98)00018-3
- Duvillard L, 2010, J CLIN ENDOCR METAB, V95, P2140, DOI 10.1210/jc.2009-2480
- Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005
- Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241
- Hussain Y, 2015, ARTERIOSCL THROM VAS, V35, P213, DOI 10.1161/ATVBAHA.114.304326
- Karjalainen A, 2000, ARTERIOSCL THROM VAS, V20, P1101, DOI 10.1161/01.ATV.20.4.1101
- KUSHWAHA RS, 1977, ANN INTERN MED, V87, P517, DOI 10.7326/0003-4819-87-5-517
- Lamon-Fava S, 2006, ARTERIOSCL THROM VAS, V26, P385, DOI 10.1161/01.ATV.0000199248.53590.e1
- Lamon-Fava S, 2003, METABOLISM, V52, P1330, DOI 10.1016/S0026-0495(03)00276-2
- Lamon-Fava S, 2008, ARTERIOSCL THROM VAS, V28, P1672, DOI 10.1161/ATVBAHA.108.164541
- Lamon-Fava S, 2007, J LIPID RES, V48, P1746, DOI 10.1194/jlr.M700067-JLR200
- Lamon-Faval S, 2004, J LIPID RES, V45, P106, DOI 10.1194/jlr.M300179-JLR200